912 total views, 1 views today
The APEX COMPANY was established in 1978, later it was taken over by the S.R.S family of Soolur, Goiyamuththur in 1982. Until now the Chairman & MD of the company Thiru.S.S.Vanagamudi has been successful in doing his duties.
With his hard work, talent and most important; his , he has raised the standard of the company to such an extent that the company now stands one among the 50 companies all over India. Right now the Apex Company has been manufacturing over 100 medicines, in Ayurvedic.
All the medicines produced & prepared by the company have been verified and certified by the department in charge. The company which has been earning around Rs.500 crores will soon start earning around Rs.750 crores.
The Apex has received the national level awards such as CII Patent & Trade Mark Award and the CII All India Innovation Award for its research in innovating new medicines.
It said that the company’s researchers (R & D Centre) have found medicines for diseases of recent times related to skin and diseases related to Diabetic Foot Ulcer, and all such diseases and have obtained the patent rights for their medicines.
Vishagan is the Executive Director of Apex Laboratories Pvt. Ltd., one of the leading family-owned pharmaceutical company in India. Vishagan comes to India after completing his graduation in Management from Bradford University, U.K. and a Masters in Management from London University. Vishagan has been instrumental in emphasizing new products.
Vishagan took charge as an Executive Director, Apex in 2016. He is the second generation entrepreneur with a strong vision to place Apex Laboratories on the global map with its 100% ethical marketing and supply of quality products. He heads the Operations and Business Development, with focus on Product Delivery, Innovation and International Business Development.
Meticulous, energetic and diligent, Vishagan sets high standards of performance for himself and his team. Under his leadership, the marketing team will design and execute unique marketing initiatives for the company, he is very passionate about infusing the concept of “Reducing the Time to Market and also redesign specific molecules for other indications” among the Management and Executives, to steer the company ahead for achieving its ambitious goals.
On his plans for the company, Vishagan said, “Apex Laboratories has always set benchmarks in the Indian pharmaceutical industry through its unique approach, well-planned business strategy, commitment to product innovation, customer care and viable business structure,”
The challenge now is to sustain the leadership position. He believes that the key to success would be customer satisfaction and this can be achieved by having individual rapport with customers. Currently, Apex is exporting to 21 countries, having established a strong domestic player, Apex is today well prepared to expand its global footprint in the coming years…..